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Abstract 
The uliginosins have potentially very useful biological activity, but their availability from natural sources is 
limited. Moreover, the one synthesis can not be reproduced. Here we report reproducible conditions for 
the synthesis of the uliginosins. 
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The uliginosins have potentially very useful biological activity, but their availability from natural sources is limited.  Moreover, the one synthesis can not be 
reproduced.  Here we report reproducible conditions for the synthesis of the uliginosins. 
 




Uliginosin A (1) and uliginosin B (2), shown in Scheme 1, are acyl 
phloroglucinols present in Hypericum gentianoides [1,2]. These 
acyl phloroglucinols showed antibacterial activity against Bacillus 
subtilis [3-5] and Staphylococcus aureus, and antifungal activity 
against Trichophyton mentagrophytes [2]. Recently, Hillwig [6] 
reported that both compounds exhibit anti-inflammatory and anti-
HIV activity.  Because H. gentianoides is not a common species 
and can be difficult to grow, the availability of quantities of 1 and 2 
depends on the development of an efficient synthetic route.  In 1978 
Meikel and Stevens reported the synthesis of 1 [7,8] and achieved 
the synthesis of 2 [9,10] by oxidation of 1 with DDQ in 8% yield. 
Unfortunately, we were unable to reproduce the synthesis of 1 due 
to the limited experimental detail. We describe herein a general 
route for the synthesis of both compounds in improved yields from 
a common intermediate. 
 
 
Scheme 1: Retrosynthesis of 1 and 2. 
 
Compounds 1 and 2 are produced from the coupling reactions of 3 
[11] with prenyl ketone 4 and benzopyran 5, respectively (Scheme 
1). Prenyl ketone 4 and benzopyran 5 are derived from the same 
compound 6 [12]. 
 
The synthesis of uliginosin A (1) required the reaction of prenyl 
ketone 4 with 3.  Although two syntheses of prenyl ketone 4 had 
been reported [13,14], the prenylation of isobutyrylphloroglucinol 
proved difficult, affording multiple products with a variety of bases 
(NaH, NaOMe and KOH). Fortunately, the reaction of isobutyryl- 
phloroglucinol with prenyl bromide at room temperature in diethyl 
 
Scheme 2: Synthesis of Compound 1. 
 
 
Scheme 3: Synthesis of Compound 2. 
 
ether and saturated aqueous Na2CO3 with copper(I) chloride as 
catalyst reproducibly provided a 46% yield of prenyl ketone 4 
(Scheme 2). Initially, the connection of 4 with 3 failed, in part 
because of the limited experimental details in the Meikel and 
Stevens paper.  After many experiments, the key coupling of 4 and 
3 to generate uliginosin A (1) was achieved in 63% yield.  The 
crucial experimental parameters were found to be the number of 
equivalents of base and the temperature. 
 
Benzopyran 5 was prepared by a route used by our group for the 
synthesis of acyl benzopyrans [15] (Scheme 3). Ketone 7 was 
generated by protection of two hydroxyl groups of compound 6 
with MOMCl, followed by selective deprotection of one MOM 
group with iodine. Base induced cyclization of ketone 7 with 3,3-
dimethyl acrolein and deprotection with HCl afforded benzopyran 
5. The reaction of benzopyran 5 with 3 afforded uliginosin B (2) in 
62% yield. 
 
In summary, direct and reproducible syntheses of uliginosins A and 
B were achieved.  The availability of these commonly occurring 
acyl phloroglucinols will permit additional studies of their 
biological activity.   
NPC Natural Product Communications 2012 Vol. 7 
No. 2 
191 - 192 
 
 
192  Natural Product Communications Vol. 7 (2) 2012 Kraus & Liu 
Experimental 
 
2,4,6-Trihydroxy-3-prenyl isobutyrophenone (4): Prenyl bromide 
(0.08 mL, 0.6 mmol) was added to a two-phase mixture consisting 
of isobutyrylphloroglucinol (58 mg, 0.29 mmol) and CuCl (2 mg, 
0.02 mmol) in diethyl ether (3 mL) and saturated aqueous Na2CO3 
(3 mL). The mixture was stirred vigorously for 5 h at room 
temperature.  After acidifying with 3N HCl, the aqueous layer was 
extracted with EtOAc (5 mL × 3). The combined organic layers 
were washed with brine and dried over Na2SO4. The solvent was 
removed in vacuo. The residue was purified by silica gel CC 
(hexanes: EtOAc = 3:1) to give pure 4 (35 mg, 46% yield). 
 
Uliginosin A (1): To a mixture of compound 3 (25 mg, 0.095 
mmol), 4 (22 mg, 0.048 mmol) and NaH (8 mg, 0.192 mmol) was 
added 3 mL of EtOH. The resulting mixture was boiled for 45 min. 
After cooling to room temperature, the solvent was removed          
in vacuo. After acidifying with 3N HCl, the aqueous layer was 
extracted with EtOAc (5 mL × 3). The combined organic layers 
were washed with brine and dried over Na2SO4. The solvent was 
removed in vacuo. The residue was purified by silica gel CC 
(hexanes: EtOAc = 1:1) to give uliginosin A (15 mg, 63% yield). 




none (7): To a solution of isobutyrylphloroglucinol (257 mg, 1.3 
mmol) in 5 mL of CH2Cl2 was added diisopropylethylamine (0.68 
mL, 3.9 mmol) at 0°C. Chloromethylmethylether (2.6 mmol) was 
then added. The mixture was stirred at 0°C for 2 h. Water was added 
to quench the reaction. CH2Cl2 (5 mL × 3) was added to the extract. 
The combined organic layers were washed with brine and dried 
over Na2SO4. The solvent was removed in vacuo. The residue was 
purified by silica gel CC (hexanes: EtOAc = 1:1) to give the 2,4-
bis-MOM ether of isobutyrylphloroglucinol (310 mg, 84% yield). 
To a solution of the 2,4-bis-MOM ether of isobutyrylphloroglucinol 
(428 mg, 1.5 mmol) in 15 mL of  MeOH was added I2 (150 mg) at 
room temperature. The resulting mixture was stirred at room 
temperature for 16 h. Saturated aqueous Na2S2O3 solution was 
added, followed by EtOAc (10 mL × 3). The combined organic 
layers were washed with brine and dried over Na2SO4. The solvent 
was removed in vacuo. The residue was purified by silica gel CC 
(hexanes: EtOAc = 1:1) to give 7 (295 mg, 82% yield). 
1H NMR (300 MHz): 6.08 (2H, s), 5.14 (2H, s), 3.86-3.95 (1H, m), 
3.45 (3H, s), 1.17-1.19 (6H, d, J=6.0 Hz).  
13C NMR (100 MHz): 19.4, 39.6, 56.6, 94.0, 96.3, 105.0, 163.2, 
163.4, 211.3.   
 
1-(5,7-Dihydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl)-2-methyl-
1-propanone (5): The solution of 7 (69 mg, 0.28 mmol) and          
3-methyl-2-butenal (0.07 mL, 0.7 mmol) in 5 mL of pyridine was 
boiled for 16 h. After cooling to room temperature, the solvent was 
removed in vacuo. The residue was purified by silica gel CC 
(hexanes: EtOAc = 5:1) to give the MOM ether of 7 (71 mg, 83% 
yield). To a solution of the MOM ether of 7 (120 mg, 0.39 mmol) in 
20 mL of MeOH was added 1.3 mL of 3N HCl. The resulting 
mixture was boiled for 25 min. After cooling to room temperature, 
the solvent was removed in vacuo. The residue was purified by 
preparative TLC (hexanes: EtOAc = 5:1) to give pure 5 (83 mg, 
81% yield). 
1H NMR (300 MHz): 6.55-6.59 (1H, d, J=12.0 Hz), 5.94 (1H, s), 
5.41-5.44 (1H, d, J=9.0 Hz), 3.81-3.90 (1H, m), 1.49 (6H, s), 1.17-
1.20 (6H, d, J=9.0 Hz).  
13C NMR (100 MHz): 19.6, 28.0, 39.4, 78.3, 96.4, 102.3, 105.2, 
116.7, 124.6, 156.7, 158.5, 166.2, 210.8. 
 
Uliginosin B (2): To a mixture of compound 5 (30 mg, 0.065 
mmol), 3 (36 mg, 0.13 mmol) and NaH (11 mg, 0.26 mmol) was 
added 3 mL of EtOH. The resulting mixture was boiled for 45 min. 
After cooling to room temperature, the solvent was removed in 
vacuo. After acidifying with 3N HCl, EtOAc (5 mL × 3) was added 
to the extract. The combined organic layers were washed with brine 
and dried over Na2SO4. The solvent was removed in vacuo. The 
residue was purified by silica gel CC (hexanes: EtOAc = 5:1) to 
give uliginosin B (20 mg, 62% yield). The proton and carbon NMR 
spectra were identical to the literature spectra [16]. 
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